First RSV Vaccine to Protect Newborns against Severe Infection Available
Centers for Disease Control and Prevention
2023 fall–winter is the first season when vaccines for all three major respiratory viruses are available
Vaccines
Dendritic Cell Vaccine Safe and Immunogenic against Multiple Myeloma
American Association for Cancer Research
Vaccination given in combination with autologous stem cell transplant was associated with long-term disease control
HIV Vaccine Phase 1 Trial Begins in the US and South Africa
National Institutes of Health
Novel vaccine uses weakened cytomegalovirus as a vector to deliver and alert the immune system
Phase 1 Trial of Universal Flu Vaccine Candidate Begins
National Institute of Allergy and Infectious Diseases
Nanoparticle vaccine targets six flu strains and may need to be taken less than once a year
Multidrug-Resistant Klebsiella Emerging in Community Settings
National Institutes of Health
Researchers study the confluence of multidrug resistance and hypervirulence in Klebsiella pneumoniae
Mpox Vaccine Helps Reduce Disease Severity
Queen Mary University of London
This largest study and only case series examines reinfections and infections after a complete MVA–BN vaccine course
Fentanyl, Heroin Vaccines to Enter Phase 1 Trials Soon
University of Montana
Researchers, partners are working on good manufacturing practices to scale up and support vaccines’ clinical trials
Quality of Cold: What it Means and Why it Matters
Vaccine cold chain management
FDA Approves First RSV Vaccine for Pregnant Individuals
U.S. Food and Drug Administration
According to the CDC, RSV is the leading cause of infant hospitalization in the US and warrants immediate preventive action
CDC Recommends mAbs to Prevent RSV in Infants
Centers for Disease Control and Prevention
New immunization is the first approved and recommended in the US to prevent severe RSV disease in all infants